Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-04 Purchase | 2024-03-06 4:05 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 10,684 | $9.38 | $100,216 | 301,733 (Direct) | View |
| 2023-09-15 Purchase | 2023-09-18 5:07 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 36,072 | $8.32 | $300,119 | 188,730 (Direct) | View |
| 2022-11-21 Sale | 2022-11-23 4:05 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 6,578 | $11.56 | $76,042 | 78,422 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-23 Option Award | 2024-05-28 8:02 pm | N/A 2034-05-23 | Assertio Holdings Inc. | ASRT | Emany Sravan Kumar Director | 134,975 | $0 | 312,545 (Direct) | View |
| 2024-05-16 Tax Withholding | 2024-05-20 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 18,280 | $6.64 | 320,573 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-12 4:05 pm | N/A 2026-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 37,120 | $0 | 338,853 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:39 pm | N/A 2027-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 97,968 | $0 | 323,705 (Direct) | View |
| 2024-02-08 Tax Withholding | 2024-02-12 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 41,332 | $14.9 | 225,737 (Direct) | View |
| 2024-01-17 Option Award | 2024-01-19 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 85,000 | $0 | 267,069 (Direct) | View |
| 2023-11-16 Tax Withholding | 2023-11-20 4:05 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 6,661 | $9.44 | 182,069 (Direct) | View |
| 2023-11-14 Option Award | 2023-11-16 8:05 pm | N/A 2023-11-14 | Assertio Holdings Inc. | ASRT | Emany Sravan Kumar Director | 203,878 | $0 | 203,878 (Direct) | View |
| 2023-03-08 Option Award | 2023-03-10 5:08 pm | N/A 2026-02-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 111,354 | $0 | 189,776 (Direct) | View |
| 2021-12-06 Option Award | 2021-12-08 4:09 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer | 85,000 | $0 | 85,000 (Direct) | View |